SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Y.-P. Su, C.-K. Chang, R. D. Hayes, S. Harrison, W. Lee, M. Broadbent, D. Taylor, R. Stewart, Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome, Acta Psychiatrica Scandinavica, 2014, 129, 5
  2. 2
    Mark B. Detweiler, Kelly Sullivan, Taral R. Sharma, Kye Y. Kim, Jonna G. Detweiler, Case Reports of Neuroleptic Malignant Syndrome in Context of Quetiapine Use, Psychiatric Quarterly, 2013, 84, 4, 523

    CrossRef

  3. 3
    Young-Sook Kwack, Jae-Sung Ryu, Neuroleptic Malignant Syndrome in Children and Adolescents : A Review, Journal of korean Academy of Child and Adolescent Psychiatry, 2013, 24, 1, 13

    CrossRef

  4. 4
    Anupam Verma, Angharad Ruttley, A diagnostic dilemma between psychosis, neuroleptic malignant syndrome and encephalitis, Neuropsychiatry, 2012, 2, 1, 23

    CrossRef

  5. 5
    Julie Langan, Daniel Martin, Polash Shajahan, Daniel J Smith, Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report, BMC Psychiatry, 2012, 12, 1, 214

    CrossRef

  6. 6
    Jonathan E. Sevransky, O. Joseph Bienvenu, Karin J. Neufeld, Dale M. Needham, Treatment of four psychiatric emergencies in the intensive care unit, Critical Care Medicine, 2012, 40, 9, 2662

    CrossRef

  7. You have free access to this content7
    Ümit Tural, Emin Önder, Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death, Psychiatry and Clinical Neurosciences, 2010, 64, 1
  8. 8
    Robert S. Hockberger, John R. Richards, Rosen's Emergency Medicine – Concepts and Clinical Practice, 2010,

    CrossRef

  9. 9
    Pierre Thomas, Köksal Alptekin, Mihai Gheorghe, Mauro Mauri, José Manuel Olivares, Michael Riedel, Management of Patients Presenting with Acute Psychotic Episodes of Schizophrenia, CNS Drugs, 2009, 23, 3, 193

    CrossRef

  10. 10
    Dallas P. Seitz, Sudeep S. Gill, Neuroleptic Malignant Syndrome Complicating Antipsychotic Treatment of Delirium or Agitation in Medical and Surgical Patients: Case Reports and A Review of the Literature, Psychosomatics, 2009, 50, 1, 8

    CrossRef

  11. 11
    SA Al-Edrus, R Norzaini, R Chua, SD Puvanarajah, M Shuguna, S Muda, Reversible splenial lesion syndrome in neuroleptic malignant syndrome, Biomedical Imaging and Intervention Journal, 2009, 5, 4

    CrossRef

  12. 12
    Yan Chen, Jeff J. Guo, Michael Steinbuch, Peter F. Buckley, Nick C. Patel, Risk of Neuroleptic Malignant Syndrome in Patients with Bipolar Disorder: A Retrospective, Population-Based Case-Control Study, The International Journal of Psychiatry in Medicine, 2009, 39, 4, 439

    CrossRef

  13. 13
    The Maudsley Prescribing Guidelines, Tenth Edition, 2009,

    CrossRef

  14. 14
    Meyler's Side Effects of Psychiatric Drugs, 2009,

    CrossRef

  15. 15
    C. Harter, C. Obier, K.-F. Druschky, B. Eikelmann, Malignes neuroleptisches Syndrom durch Amisulprid, Der Nervenarzt, 2008, 79, 1, 86

    CrossRef

  16. 16
    Amy T. Sheil, Kim A. Collins, Cynthia A. Schandl, Russell A. Harley, Fatal Neurotoxic Response to Neuroleptic Medications, The American Journal of Forensic Medicine and Pathology, 2007, 28, 2, 116

    CrossRef

  17. 17
    NAOHISA TSUCHIYA, ERI MORIMURA, TETSUJI HANAFUSA, TETSUTARO SHINOMURA, Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy, Pediatric Anesthesia, 2007, 17, 3
  18. 18
    Ljiljana J Verner, Claudia L Kollmar, Detlef E Dietrich, Neuroleptic malignant syndrome or haloperidol toxicity: a case report and differential diagnosis, Journal of Psychiatric Intensive Care, 2006, 2, 02, 122

    CrossRef

  19. 19
    Toru Sanai, Rei Matsui, Tadashi Hirano, Shinichi Torichigai, Hideki Yotsueda, Harumichi Higashi, Hideki Hirakata, Mitsuo Iida, Successful Treatment of Six Patients with Neuroleptic Malignant Syndrome Associated with Myoglobulinemic Acute Renal Failure, Renal Failure, 2006, 28, 1, 51

    CrossRef

  20. 20
    J. Nielsen, A. M. Bruhn, Atypical neuroleptic malignant syndrome caused by olanzapine, Acta Psychiatrica Scandinavica, 2005, 112, 3
  21. 21
    Catherine A. Marco, Jason Vaughan, Emergency management of agitation in schizophrenia, The American Journal of Emergency Medicine, 2005, 23, 6, 767

    CrossRef

  22. 22
    Masanori Nagamine, Aihide Yoshino, Yutaka Sakurai, Masaki Sanga, Ryuichi Takahashi, Soichiro Nomura, Exacerbating Factors in Neuroleptic Malignant Syndrome, Journal of Clinical Psychopharmacology, 2005, 25, 5, 499

    CrossRef

  23. 23
    E. Pufal, M. Sykutera, P. Engelgardt, G. Rochholz, K. Śliwka, Untersuchungen zur Bestimmung und Stabilität von Risperidon in Körperflüssigkeiten und postmortalen Gewebeproben, Rechtsmedizin, 2005, 15, 5, 389

    CrossRef

  24. 24
    The Maudsley 2005-2006 Prescribing Guidelines, 2005,

    CrossRef

  25. 25
    Alfonso Carvajal, Luis H. Martín Arias, Natalia Jimeno, 2005,

    CrossRef

  26. 26
    Christopher T. Manetta, Julie P. Gentile, Psychotropic Medications,